论文部分内容阅读
目的观察参附注射液治疗急性胰腺炎（AP）的临床疗效。方法将72例AP患者随机分为治疗组和对照组，每组36例。两组均给予常规治疗，此外，治疗组加用参附注射液治疗。结果治疗组症状、体征消失时间及住院时间均明显短于对照组（P<0.01），实验室指标较对照组改善更明显（P<0.01），总有效率（94.4%）也明显高于对照组（72.2%）（P<0.05）。结论参附注射液能明显改善AP患者的症状、体征及理化指标，缩短住院时间。“,” Objective To observe the clinical effect of Shenfu injection in treating acute pancreatitis(AP). Methods 72 patients with AP were randomly divided into therapy group and control group with each group of 36 cases, both group receiving conventional treatment, moreover, the therapy group was given Shenfu injection for 5 to 7 days. Results Compared with control group, the therapy group had shorter time of symptom and sign disappearance as wel as hospital stays, better improvement of laboratory indexes, and higher total effectiveness rate(P<0.01 or P<0.05). Conclusion Shenfu injection can significantly improve symptoms, signs and physical and chemical indexes of patients with AP, shorten hospital stays.